Morgan Goodwin is a UK-based company that pioneers the Combined Trading Platform (CTP) category, offering a comprehensive online platform for small businesses engaged in physical goods trading, along with specialized software development services, and a broad-spectrum business consultancy approach aimed at enhancing growth, efficiency, and technological advancement.
days to go:
Stretch
investment:
£788,519
Doqit offers a solution for managing life admin tasks, helping you organize important information, set action dates, and receive timely reminders, ultimately streamlining tasks like insurance renewals and warranties to reduce unnecessary expenses and simplify your life. It provides secure storage and easy access for vital information, transitioning from chaos to simplicity.
Security is also a priority for Doqit. The platform ensures that your sensitive information is stored securely, giving you peace of mind knowing that you can access your important documents and data whenever you need them, all within a few clicks.
days to go:
Extended
investment:
£87,500
UTU is a company dedicated to building the trust infrastructure for the evolving web 3.0. They aim to facilitate safer and more reliable interactions between users and platforms by utilizing a decentralized reputation and reviews protocol. This protocol involves a non-tradable reputation token (UTT) that users can stake to endorse others, leading to positive outcomes. UTU's focus initially lies in Web3 and DeFi apps, where they provide AI-powered tools to curate trust signals and help users engage confidently in various online activities. They offer a range of products, including the UTU Trust Token, Browser Extension, and Trust API/SDK, all aimed at enhancing trust and security in digital interactions.
days to go:
Extended
investment:
£150,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
ZOA Robotics build robots which have been inspired by nature. They are currently focusing on low-cost 4-legged systems for the transportation of materials on uneven ground. ZOA's founder has experience in the robotics industry and has already created impressive initial prototypes of the product.
days to go:
Expired
investment:
£188,300
Elute Intelligence is an online platform that makes searching documents fast, simple, and accurate. The platform is optimised to handle a variety of tasks such as plagiarism detection, patent searching, fraud detection, governance and compliance, and e-discovery to name a few. Using a unique AI-based system, users can upload long-form documentation, and the system will analyse, tag, and find related articles across a wide range of academic journals and data sources. The company is looking to engage in partnerships: with government and commercial R&D teams to help accelerate research into Covid-19, with development partners to help expand the system into other research areas, and with investors interested in an AI and big data platform that can transform scientific research processes.
days to go:
Expired
investment:
Withheld
Ever Insight (EI) offers professional analytics services catered to a customer's needs. The company platform draws valuable insights from data ensuring that business managers can make efficient decisions. EI specialises in three main verticals namely, Predictive Learning Analytics (PLA), Financial Analytics (FA) and HR Analytics (HA). EI's current mission is to deliver an innovative and supportive analytics system to institutions that facilitate learning and eliminate roadblocks to student success. Its team has already developed the software and implemented it in India, but the company needs further refinement and adaptation to suit the UK educational market requirements. It will use the investment to get its Start-up visa approved and establish its business at different verticals.
days to go:
Expired
investment:
Withheld
Zone V makes the latest tablets and smartphones work for the older generation with low eyesight, deficient hearing or dexterity. The company has redefined a global platform that is providing access to the services that are difficult to use. They have a technological partnership with Samsung and are a Samsung Managed Solutions Partner. The company also creates inclusively accessible technology, services, and applications for more smoother and viable communication. The executive team of this company includes health, telecoms, and wellness fields. With the proceeds, Zone V will widen the digital divide for the older smartphones users by working tirelessly to build new innovative communication solutions.
days to go:
Expired
investment:
£500,000
Itasca Wines is a Hampshire-based vineyard and winery that produces fine English wines. The company is raising funds for its contract winemaking facility, to fulfil the growing demand from vineyards. There are over 760 vineyards in the UK currently, 111 have their own winery and only a handful of these provide contract winemaking services to other vineyards. Itasca Wines aims to become a major winemaker and create award-winning wines at Penn Croft. The company planted its first vineyard of 16,000 vines in May 2019 and has featured in Vineyard Magazine in February and May 2019.
days to go:
Expired
investment:
£1,147,003
Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
days to go:
Expired
investment:
Withheld
